多发性-话题@MedSci

#多发性#

905篇内容 | 2991人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890171, encodeId=607f18901e152, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:意大利多发性硬化患者中不同剂量那他珠单抗间隔给药方案的临床疗效, objectType=article, longId=202250, objectId=cdec202250b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdec202250b9, replyNumber=0, likeNumber=82, createdTime=2021-05-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdec202250b9, moduleTitle=JNNP:意大利多发性硬化患者中不同剂量那他珠单抗间隔给药方案的临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdec202250b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890167, encodeId=5b0f189016ef7, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Acta Neuropathologica: 人脑组织中1q染色体镶嵌三体与单侧多发性脑回、早发局灶性癫痫和严重发育迟缓有关, objectType=article, longId=201465, objectId=e69020146577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e69020146577, replyNumber=0, likeNumber=69, createdTime=2021-01-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e69020146577, moduleTitle=Acta Neuropathologica: 人脑组织中1q染色体镶嵌三体与单侧多发性脑回、早发局灶性癫痫和严重发育迟缓有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e69020146577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890179, encodeId=b8c718901e962, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=诺诚健华奥布替尼获FDA批准开展治疗多发性硬化症II期临床, objectType=article, longId=202926, objectId=e79820292602, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e79820292602, replyNumber=0, likeNumber=63, createdTime=2021-07-10, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e79820292602, moduleTitle=诺诚健华奥布替尼获FDA批准开展治疗多发性硬化症II期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e79820292602)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890201, encodeId=a6b9189020109, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=BRAIN：脑TSPO-PET预测多发性硬化症的复发, objectType=article, longId=205162, objectId=3724205162ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3724205162ee, replyNumber=0, likeNumber=56, createdTime=2021-03-14, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3724205162ee, moduleTitle=BRAIN：脑TSPO-PET预测多发性硬化症的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3724205162ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890147, encodeId=6bd1189014eec, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：卡非佐米-来那度胺-地塞米松联合干细胞移植治疗多发性骨髓瘤, objectType=article, longId=199134, objectId=f4861991340d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4861991340d, replyNumber=0, likeNumber=87, createdTime=2021-07-11, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4861991340d, moduleTitle=Blood：卡非佐米-来那度胺-地塞米松联合干细胞移植治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4861991340d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890118, encodeId=634d189011894, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：达雷木单抗+来那度胺+硼替佐米和地塞米松治疗新确诊的可移植的多发性骨髓瘤的疗效, objectType=article, longId=193457, objectId=c65219345ee6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c65219345ee6, replyNumber=0, likeNumber=70, createdTime=2020-09-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c65219345ee6, moduleTitle=Blood：达雷木单抗+来那度胺+硼替佐米和地塞米松治疗新确诊的可移植的多发性骨髓瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c65219345ee6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890107, encodeId=b621189010e42, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JACC：对多发性亚临床动脉粥样硬化的短期进展, objectType=article, longId=191642, objectId=239a19164240, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=239a19164240, replyNumber=0, likeNumber=101, createdTime=2020-05-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=239a19164240, moduleTitle=JACC：对多发性亚临床动脉粥样硬化的短期进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=239a19164240)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890193, encodeId=82a51890193fc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Leukemia：达拉图单抗加来那度胺和地塞米松治疗复发/难治性多发性骨髓瘤, objectType=article, longId=204246, objectId=e82d2042465f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e82d2042465f, replyNumber=0, likeNumber=71, createdTime=2021-10-03, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e82d2042465f, moduleTitle=Leukemia：达拉图单抗加来那度胺和地塞米松治疗复发/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e82d2042465f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890151, encodeId=3af118901510e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Acta Neurol Scand：多发性硬化症患者补充维生素D3是否会增加其疾病的复发风险？, objectType=article, longId=199545, objectId=a57c199545ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a57c199545ca, replyNumber=0, likeNumber=78, createdTime=2021-04-14, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a57c199545ca, moduleTitle=Acta Neurol Scand：多发性硬化症患者补充维生素D3是否会增加其疾病的复发风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a57c199545ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890146, encodeId=04031890146f5, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=GSK治疗多发性骨髓瘤的抗BCMA药物获批，再度回归抗肿瘤领域, objectType=article, longId=199021, objectId=957e19902101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=957e19902101, replyNumber=0, likeNumber=82, createdTime=2020-12-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=957e19902101, moduleTitle=GSK治疗多发性骨髓瘤的抗BCMA药物获批，再度回归抗肿瘤领域, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=957e19902101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890138, encodeId=949b189013832, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=靶向BCMA的ADC药物belantamab mafodotin，获得FDA咨询小组支持治疗复发或难治的多发性骨髓瘤患者, objectType=article, longId=197577, objectId=fa9619e5777b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa9619e5777b, replyNumber=0, likeNumber=81, createdTime=2021-05-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa9619e5777b, moduleTitle=靶向BCMA的ADC药物belantamab mafodotin，获得FDA咨询小组支持治疗复发或难治的多发性骨髓瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa9619e5777b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890177, encodeId=3ae018901e7e4, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet Oncol：Venetoclax联合硼替佐米和地塞米松显著改善复发/难治性多发性骨髓瘤患者预后, objectType=article, longId=202758, objectId=f190202e5813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f190202e5813, replyNumber=0, likeNumber=82, createdTime=2021-10-18, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f190202e5813, moduleTitle=Lancet Oncol：Venetoclax联合硼替佐米和地塞米松显著改善复发/难治性多发性骨髓瘤患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f190202e5813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890109, encodeId=29c81890109da, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=PNAS：苹果皮中的化合物可逆转多发性硬化症中的神经元损伤, objectType=article, longId=192112, objectId=46fd1921128c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46fd1921128c, replyNumber=0, likeNumber=61, createdTime=2021-03-11, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46fd1921128c, moduleTitle=PNAS：苹果皮中的化合物可逆转多发性硬化症中的神经元损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46fd1921128c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890131, encodeId=1130189013115, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性内分泌肿瘤综合征丨影像诊断, objectType=article, longId=196341, objectId=5f5419634113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5419634113, replyNumber=0, likeNumber=0, createdTime=2021-03-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5419634113, moduleTitle=多发性内分泌肿瘤综合征丨影像诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f5419634113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890094, encodeId=4fb3189009453, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Biol Blood Marrow Transplant：自体造血干细胞移植可逆转多发性骨髓瘤患者的肾功能衰竭, objectType=article, longId=189154, objectId=b1c0189154d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1c0189154d4, replyNumber=0, likeNumber=91, createdTime=2021-01-05, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1c0189154d4, moduleTitle=Biol Blood Marrow Transplant：自体造血干细胞移植可逆转多发性骨髓瘤患者的肾功能衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1c0189154d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890089, encodeId=ba0218900890f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2020专家共识建议：改善ATTR淀粉样变性伴多发性神经病的诊断, objectType=article, longId=186462, objectId=0926186462b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0926186462b4, replyNumber=0, likeNumber=14, createdTime=2020-08-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0926186462b4, moduleTitle=2020专家共识建议：改善ATTR淀粉样变性伴多发性神经病的诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0926186462b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890144, encodeId=2287189014481, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=**靶向BCMA的抗体药物偶联物Blenrep获FDA加速批准：治疗复发或难治性多发性骨髓瘤, objectType=article, longId=198901, objectId=876c19890119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=876c19890119, replyNumber=0, likeNumber=0, createdTime=2021-04-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=876c19890119, moduleTitle=**靶向BCMA的抗体药物偶联物Blenrep获FDA加速批准：治疗复发或难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=876c19890119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890142, encodeId=082f1890142b7, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：应以微小残留病灶检测阴性作为高风险多发性骨髓瘤的治疗终点, objectType=article, longId=198719, objectId=0657198e19d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0657198e19d6, replyNumber=0, likeNumber=72, createdTime=2021-04-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0657198e19d6, moduleTitle=Blood：应以微小残留病灶检测阴性作为高风险多发性骨髓瘤的治疗终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0657198e19d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890153, encodeId=7a991890153fb, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA批准也是**一个多发性硬化症患者自行注射的B细胞疗法Kesimpta（ofatumumab），只需每月注射一次, objectType=article, longId=199785, objectId=1282199e85f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1282199e85f7, replyNumber=0, likeNumber=118, createdTime=2021-06-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1282199e85f7, moduleTitle=FDA批准也是**一个多发性硬化症患者自行注射的B细胞疗法Kesimpta（ofatumumab），只需每月注射一次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1282199e85f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890143, encodeId=c8561890143ae, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NEJM：诺华每月注射一次的奥法木单抗ofatumumab在多发性硬化症患者中展现优越疗效, objectType=article, longId=198891, objectId=c95419889159, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95419889159, replyNumber=0, likeNumber=83, createdTime=2021-04-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95419889159, moduleTitle=NEJM：诺华每月注射一次的奥法木单抗ofatumumab在多发性硬化症患者中展现优越疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95419889159)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:意大利多发性硬化患者中不同剂量那他珠单抗间隔给药方案的临床疗效

2021-05-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Acta Neuropathologica: 人脑组织中1q染色体镶嵌三体与单侧多发性脑回、早发局灶性癫痫和严重发育迟缓有关

2021-01-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

诺诚健华奥布替尼获FDA批准开展治疗多发性硬化症II期临床

2021-07-10

jml2009 (审核中...)

前往app查看评论内容

#多发性#

BRAIN：脑TSPO-PET预测多发性硬化症的复发

2021-03-14

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：卡非佐米-来那度胺-地塞米松联合干细胞移植治疗多发性骨髓瘤

2021-07-11

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：达雷木单抗+来那度胺+硼替佐米和地塞米松治疗新确诊的可移植的多发性骨髓瘤的疗效

2020-09-02

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JACC：对多发性亚临床动脉粥样硬化的短期进展

2020-05-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Leukemia：达拉图单抗加来那度胺和地塞米松治疗复发/难治性多发性骨髓瘤

2021-10-03

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Acta Neurol Scand：多发性硬化症患者补充维生素D3是否会增加其疾病的复发风险？

2021-04-14

jml2009 (审核中...)

前往app查看评论内容

#多发性#

GSK治疗多发性骨髓瘤的抗BCMA药物获批，再度回归抗肿瘤领域

2020-12-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

靶向BCMA的ADC药物belantamab mafodotin，获得FDA咨询小组支持治疗复发或难治的多发性骨髓瘤患者

2021-05-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet Oncol：Venetoclax联合硼替佐米和地塞米松显著改善复发/难治性多发性骨髓瘤患者预后

2021-10-18

jml2009 (审核中...)

前往app查看评论内容

#多发性#

PNAS：苹果皮中的化合物可逆转多发性硬化症中的神经元损伤

2021-03-11

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性内分泌肿瘤综合征丨影像诊断

2021-03-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Biol Blood Marrow Transplant：自体造血干细胞移植可逆转多发性骨髓瘤患者的肾功能衰竭

2021-01-05

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2020专家共识建议：改善ATTR淀粉样变性伴多发性神经病的诊断

2020-08-23

jml2009 (审核中...)

前往app查看评论内容

#多发性#

**靶向BCMA的抗体药物偶联物Blenrep获FDA加速批准：治疗复发或难治性多发性骨髓瘤

2021-04-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：应以微小残留病灶检测阴性作为高风险多发性骨髓瘤的治疗终点

2021-04-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA批准也是**一个多发性硬化症患者自行注射的B细胞疗法Kesimpta（ofatumumab），只需每月注射一次

2021-06-23

zhouqu_8 (审核中...)

前往app查看评论内容

#多发性#

NEJM：诺华每月注射一次的奥法木单抗ofatumumab在多发性硬化症患者中展现优越疗效

2021-04-12

科室
- - 订阅+
  - 更多科室
工具
服务